Otonomy to Report Third Quarter 2019 Financial Results and Provide Corporate Update
October 29 2019 - 4:05PM
Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced it will report financial results for
the third quarter 2019 as well as provide a corporate update at
4:30 p.m. EST on November 5, 2019.
The live call may be accessed by dialing (877) 305-6769 for
domestic callers and (678) 562-4239 for international callers with
conference ID code number: 6045449. A live webcast of the call will
be available online in the investor relations section of Otonomy’s
website at www.otonomy.com and will be archived there for 30
days.
About OtonomyOtonomy is a
biopharmaceutical company dedicated to the development of
innovative therapeutics for neurotology. The company pioneered the
application of drug delivery technology to the ear in order to
develop products that achieve sustained drug exposure from a single
local administration. This approach is covered by a broad patent
estate and is being utilized to develop a pipeline of products
addressing important unmet medical needs including Ménière’s
disease, hearing loss, and tinnitus. For additional information
please visit www.otonomy.com.
Contacts:
Media InquiriesSpectrum ScienceLeticia DiazVice
President202.587.2517ldiaz@spectrumscience.com Investor
InquiriesWestwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024